Net income
−$748K
+28% vs same quarter last year
EPS, diluted
$0.01
−50% vs same quarter last year
Operating cash flow
−$626K
+17.5% vs same quarter last year
Operating income
−$732K
+22% vs same quarter last year
Source: SEC XBRL filings · latest filing
News
No stories filed under Revium Rx. yet - coverage appears here as the news feed clusters it.